|
| 36572991 | CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study. | Cancer | 2023 |
| 36948887 | p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2023 |
| 34897700 | Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas. | J Pathol | 2022 |
| 35735440 | Growing Teratoma Syndrome in the Setting of Sarcoidosis: A Case Report and Literature Review. | Curr Oncol | 2022 |
| 32554541 | Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). | Clin Cancer Res | 2020 |
| 31239549 | A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. | Mod Pathol | 2019 |
| 29061645 | Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer. | Clin Cancer Res | 2018 |
| 29854515 | A Vaginal Angiomyofibroblastoma as a Rare Cause of a Prolapsing Vaginal Mass: A Case Report and Review of the Literature. | Case Rep Obstet Gynecol | 2018 |
| 30062862 | Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2018 |
| 29502561 | MyD88 and TLR4 Expression in Epithelial Ovarian Cancer. | Mayo Clin Proc | 2018 |
| 29531130 | Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study. | Cancer Epidemiol Biomarkers Prev | 2018 |
| 28646021 | <i>EIF1AX</i> and <i>NRAS</i> Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas. | Cancer Res | 2017 |
| 29049607 | Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. | JAMA Oncol | 2017 |
| 28677147 | Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination. | Int J Cancer | 2017 |
| 27031538 | Ipilimumab-induced acute generalized exanthematous pustulosis in a patient with metastatic melanoma. | Melanoma Res | 2016 |
| 24134067 | Localized cutaneous immunoglobulin G4. | Int J Dermatol | 2015 |
| 26506417 | Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes. | Oncotarget | 2015 |
| 26037119 | Fungal Inositol Pyrophosphate IP7 Is Crucial for Metabolic Adaptation to the Host Environment and Pathogenicity. | mBio | 2015 |
| 25748298 | Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy. | J Am Acad Dermatol | 2015 |
| 24505588 | What is your diagnosis? eruptive syringoma. | Cutis | 2014 |
| 25316818 | Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. | Clin Cancer Res | 2014 |
| 24513809 | Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis. | Clin Immunol | 2014 |
| 23557327 | Effects of BRAF inhibitors on human melanoma tissue before treatment, early during treatment, and on progression. | Pigment Cell Melanoma Res | 2013 |
| 23619586 | Gastrointestinal amyloidosis associated with Schnitzler's syndrome. | Pathology | 2013 |
| 22156613 | Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma. | Clin Cancer Res | 2012 |
| 23031375 | Kikuchi-Fujimoto disease with cutaneous presentation in a patient with subacute cutaneous lupus erythematosus. | Dermatol Online J | 2012 |
| 22962325 | Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine. | Mol Cancer Ther | 2012 |
| 22804352 | Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma. | Br J Dermatol | 2012 |
| 22833082 | Ovarian teratoma associated with anti-N-methyl D-aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates. | Int J Gynecol Pathol | 2012 |
| 22435737 | Plexiform fibrohistiocytic tumour: morphological changes and challenges in assessment of recurrent and metastatic lesions. | Histopathology | 2012 |
| 21423607 | Comparison of expression profiles in ovarian epithelium in vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis. | PLoS One | 2011 |
| 21864259 | Anti-arthritic effects of immunomodulatory peptide injected in joints. | Curr Drug Deliv | 2011 |
| 21976534 | Copy number aberrations in benign serous ovarian tumors: a case for reclassification? | Clin Cancer Res | 2011 |
| 19117973 | The histological features of intestinal spirochetosis in a series of 113 patients. | Int J Surg Pathol | 2010 |
| 21080881 | Dieulafoy's disease of the bronchus. | Pathology | 2010 |
| 20546349 | Melanoma exhibiting cartilaginous differentiation. | Histopathology | 2010 |
| 20633792 | Cutaneous epithelioid angiosarcoma occurring at a peristomal site. | J Am Acad Dermatol | 2010 |
| 20632833 | Fibrosarcomatous variant of dermatofibrosarcoma protuberans showing COL1A1-PDGFB gene fusion, detected using a novel and disease-specific RT-PCR protocol. | Pathology | 2010 |
| 20229506 | Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. | J Pathol | 2010 |
| 20350228 | Composite phaeochromocytoma-ganglioneuroma, an uncommon entity: report of two cases. | Pathology | 2010 |
| 18000712 | Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). | Ann Surg Oncol | 2008 |
| 19010816 | Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors. | Mol Cancer Res | 2008 |
| 18980987 | Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer. | Clin Cancer Res | 2008 |
| 18269479 | Diagnosis and management of sebaceous carcinoma: an Australian experience. | ANZ J Surg | 2008 |
| 17606713 | Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma. | Clin Cancer Res | 2007 |
| 16684332 | Metaplastic ossification in mammary fibroadenoma. | Breast J | 2006 |
| 15487450 | Micromorphometric features of positive sentinel lymph nodes predict involvement of nonsentinel nodes in patients with melanoma. | Am J Clin Pathol | 2004 |
| 15372052 | Antimony concentrations in nodal tissue can confirm sentinel node identity. | Mod Pathol | 2004 |
| 15221927 | Pathology of melanocytic lesions: new, controversial, and clinically important issues. | J Surg Oncol | 2004 |
| 15305156 | Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens. | Melanoma Res | 2004 |